Fenugreek derived diosgenin as an emerging source for diabetic therapy

Area of Science:

• Pharmacology
• Metabolic Diseases
• Nutraceuticals

Background:

• Diabetes mellitus is a chronic metabolic disorder characterized by impaired glucose and insulin regulation, leading to widespread tissue and organ damage.
• Pathological changes in diabetes include pancreatic cell damage and alterations in crucial signaling pathways like Akt, PKC/GLUT4, and PPAR.
• Associated complications affect cardiovascular, nervous, hepatic, renal, and ocular systems, highlighting the systemic impact of diabetes.

Purpose of the Study:

• To explore the potential of diosgenin, a fenugreek-derived steroidal compound, as a nutraceutical for diabetes management.
• To investigate the extraction, purification, and pharmacological properties of diosgenin.
• To elucidate the mode of action of diosgenin in addressing diabetes-related metabolic dysfunctions.

Main Methods:

• Review of scientific literature on diosgenin, fenugreek bioactive compounds, and diabetes pathophysiology.
• Analysis of pathways affected by diosgenin, including glucose transport, insulin signaling, and gene expression related to lipid metabolism.
• Examination of diosgenin's inhibitory effects on enzymes like α-amylase and α-glucosidase.

Main Results:

• Diosgenin influences cellular pathways involved in glucose and insulin regulation, potentially counteracting diabetes-induced damage.
• It modulates key metabolic pathways, including those involving Akt, PKC/GLUT4, and PPAR, and inhibits enzymes crucial for carbohydrate digestion.
• Diosgenin may also impact gene expression related to fatty acid synthesis and reduce levels of proteins associated with apoptosis in pancreatic cells.

Conclusions:

• Diosgenin, a bioactive compound from fenugreek, demonstrates significant potential in managing diabetes through multifaceted mechanisms.
• Its ability to modulate critical metabolic pathways and enzyme activities offers a promising therapeutic avenue for diabetes prevention and treatment.
• Further research into diosgenin's extraction, purification, and clinical efficacy is warranted for its development as a novel nutraceutical intervention.